Vitamin D and 1,25(OH)2D Regulation of T cells

被引:395
作者
Cantorna, Margherita T. [1 ,2 ]
Snyder, Lindsay [1 ]
Lin, Yang-Ding [1 ]
Yang, Linlin [1 ]
机构
[1] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA
[2] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA
关键词
D-RECEPTOR EXPRESSION; 1,25-DIHYDROXYVITAMIN D-3; NKT CELLS; IN-VIVO; ACTIVATION; IMMUNITY; IL-10; MICE; DIFFERENTIATION; PROLIFERATION;
D O I
10.3390/nu7043011
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Vitamin D is a direct and indirect regulator of T cells. The mechanisms by which vitamin D directly regulates T cells are reviewed and new primary data on the effects of 1,25 dihydroxyvitamin D (1,25(OH)(2)D) on human invariant natural killer (iNK)T cells is presented. The in vivo effects of vitamin D on murine T cells include inhibition of T cell proliferation, inhibition of IFN-gamma, IL-17 and induction of IL-4. Experiments in mice demonstrate that the effectiveness of 1,25(OH)(2)D requires NKT cells, IL-10, the IL-10R and IL-4. Comparisons of mouse and human T cells show that 1,25(OH)(2)D inhibits IL-17 and IFN-gamma, and induces T regulatory cells and IL-4. IL-4 was induced by 1,25(OH)(2)D in mouse and human iNKT cells. Activation for 72h was required for optimal expression of the vitamin D receptor (VDR) in human and mouse T and iNKT cells. In addition, T cells are potential autocrine sources of 1,25(OH)(2)D but again only 48-72h after activation. Together the data support the late effects of vitamin D on diseases like inflammatory bowel disease and multiple sclerosis where reducing IL-17 and IFN-gamma, while inducing IL-4 and IL-10, would be beneficial.
引用
收藏
页码:3011 / 3021
页数:11
相关论文
共 61 条
[1]   Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity [J].
Akbari, O ;
Stock, P ;
Meyer, E ;
Kronenberg, M ;
Sidobre, S ;
Nakayama, T ;
Taniguchi, M ;
Grusby, MJ ;
DeKruyff, RH ;
Umetsu, DT .
NATURE MEDICINE, 2003, 9 (05) :582-588
[2]   In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].
Barrat, FJ ;
Cua, DJ ;
Boonstra, A ;
Richards, DF ;
Crain, C ;
Savelkoul, HF ;
de Waal-Malefyt, R ;
Coffman, RL ;
Hawrylowicz, CM ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616
[3]   1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells [J].
Boonstra, A ;
Barrat, FJ ;
Crain, C ;
Heath, VL ;
Savelkoul, HFJ ;
O'Garra, A .
JOURNAL OF IMMUNOLOGY, 2001, 167 (09) :4974-4980
[4]   Intrinsic Requirement for the Vitamin D Receptor in the Development of CD8αα-Expressing T Cells [J].
Bruce, Danny ;
Cantorna, Margherita T. .
JOURNAL OF IMMUNOLOGY, 2011, 186 (05) :2819-2825
[5]   Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease [J].
Cantorna, Margherita T. ;
McDaniel, Kaitlin ;
Bora, Stephanie ;
Chen, Jing ;
James, Jamaal .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2014, 239 (11) :1524-1530
[6]   Vitamin D, multiple sclerosis and inflammatory bowel disease [J].
Cantorna, Margherita T. .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2012, 523 (01) :103-106
[7]   1,25-dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease [J].
Cantorna, MT ;
Munsick, C ;
Bemiss, C ;
Mahon, BD .
JOURNAL OF NUTRITION, 2000, 130 (11) :2648-2652
[8]   In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D3 [J].
Cantorna, MT ;
Humpal-Winter, J ;
DeLuca, HF .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2000, 377 (01) :135-138
[9]   Vitamin D receptor expression controls proliferation of naive CD8+ T cells and development of CD8 mediated gastrointestinal inflammation [J].
Chen, Jing ;
Bruce, Danny ;
Cantorna, Margherita T. .
BMC IMMUNOLOGY, 2014, 15
[10]   Vitamin D: Metabolism [J].
Christakos, Sylvia ;
Ajibade, Dare V. ;
Dhawan, Puneet ;
Fechner, Adam J. ;
Mady, Leila J. .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2012, 38 (01) :1-+